Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
The first automated solid-phase oligosaccharide synthesis was reported in 2001, using a modified Applied Biosystems 433 peptide synthesizer. It automated the step-by-step assembly of certain carbohydrate chains—not the synthesis of every kind of carbohydrate. A purpose-built instrument arrived later, in 2012.
What “carbohydrate synthesizer” means here
The historical milestone concerns an automated system for making oligosaccharides: short chains of sugar units joined by glycosidic bonds. Reviews date the first automated solid-phase oligosaccharide synthesis to 2001, using a modified peptide synthesizer. The phrase “carbohydrate synthesizer” can suggest a machine for making carbohydrates generally, but this system was designed for a specific kind of chain assembly.
The distinction matters because linking sugar units is chemically demanding. A synthesis must form the intended connection between units and control its stereochemistry—the three-dimensional arrangement at the linkage—while limiting unwanted reactions.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
How the 2001 prototype assembled sugar chains
The prototype adapted an iterative solid-phase method. A starting sugar acceptor was attached to a resin support, and the instrument delivered reagents to it in programmed cycles. After a coupling step joined a new sugar unit, excess liquids were removed and a protecting group could be removed to expose a hydroxyl group for the next coupling.
#1 Best Overall
In the prototype, argon pressure moved reagents and solvents through Teflon lines. Computer-controlled solenoid valves timed delivery into a reaction vessel holding the resin-bound material. The vessel was jacketed so circulating fluid could regulate its temperature; the chiller, however, needed manual adjustment.
How the prototype and dedicated successor differed
The first system was a modified Applied Biosystems 433, a commercially available peptide synthesizer adapted as a reliable prototype. Its peptide-focused design imposed practical limits on carbohydrate work. A specialist review identifies imprecise reagent delivery, difficulty controlling small-volume delivery rates, a limited number of reagent positions, and manual temperature adjustment among its shortcomings.
Rank #2
Seeberger and coworkers, working with Ancora Pharmaceuticals, introduced a dedicated fully automated solid-phase oligosaccharide synthesizer in 2012. A later review reports that Glyconeer 2.1 was marketed in 2013. These are separate milestones: the 2001 achievement was automation on a modified peptide machine; the later instrument was purpose-built.
| Milestone | What changed | Source-supported date |
|---|---|---|
| Modified peptide-synthesizer prototype | Automated solid-phase oligosaccharide assembly, but with delivery, reagent-position, and manual temperature-control limitations. | 2001, as dated by a 2005 review. |
| Dedicated automated synthesizer | Used syringe pumps for more precise delivery, retained pressure-driven washes, supported up to 16 reagent or building-block positions, and controlled temperature by computer. | Introduced in 2012, according to a specialist review chapter. |
| Glyconeer 2.1 | Commercial follow-on to the dedicated instrument. | Marketed in 2013, according to a 2017 review. |
What the early synthesizer made—and why it mattered
Early automated targets described in a 2008 review included three linear 1,2-α-linked mannan oligosaccharides and a branched phytoalexin elicitor β-glucan. Later work applied automated synthesis to research targets such as bacterial and cancer antigens, vaccine candidates, and N-linked core oligosaccharides. These are research applications; synthesizing a candidate antigen does not mean the instrument produced an approved vaccine or treatment.
Rank #3
The broader contribution was methodological. Automating repeated delivery, coupling, washing, and deprotection helped researchers make structurally defined glycans more reproducibly and study how particular carbohydrate structures behave biologically. It did not make every carbohydrate synthesis routine or universally accessible.
Quick Recap
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
